Diseases of the Pancreas November 19, 2007 NCDD Meeting Chair: Jane Holt Vice Chair: P. Jay Pasricha, MD.

Slides:



Advertisements
Similar presentations
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Advertisements

Clinical Signs and Characteristics of Pancreatitis
Dr. Gehan Mohamed Dr. Abdelaty Shawky
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
Al-Qassim University Faculty of Medicine Phase II – Year III GIT Block (CMD332) EXOCRINE PANCREASE Lecture Dr. Gamal Hamra Wednesday 01/12/1430 (18/11/2009)
Prepared by: Dr.Mohamed Al-Shekhani.. Diagnosis:
Combating major diseases Gender aspects in research Gender aspects in research have a particular relevance to this theme as risk factors, biological mechanisms,
Lec. 1 Dr. Abdullah K. Rabba Ph.D
Pancreas & diabetes Željka Kušter Mentor: A. Žmegač Horvat.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
General Pathology Review. Assumptions Studying pathology enables us to better treat people Normal people participate positively in the society Activity.
Introduction of Cancer Molecular Epidemiology Zuo-Feng Zhang, MD, PhD University of California Los Angeles.
INTERACTIVE QUESTIONS. Discussion Question What is central sensitization/ dysfunctional pain? Pathophysiology.
Week 1 Introduction to Pathology Dr.İ.Taci Cangül Bursa-2008.
Bioengineering, Biotechnology, and Imaging November 19, 2007 NCDD Meeting Chair: Barbara B. Bass, MD Vice Chair: David A. Lieberman, MD.
The Nature of Disease.
Unit 5 – Public Health Chronic Diseases
Infections of the GI Tract November 19, 2007 NCDD Meeting Chair: Mitchell B. Cohen, MD Vice Chair: Richard S. Blumberg, MD.
Introduction to Pathology
Chapter 13 Disorders of the Pancreas
INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS:
Chronic pain Sai Yan Au. Chronic Pain  Definition  Causes and mechanisms of chronic pain  Effects of chronic pain  Assessment and evaluation  Management.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA Erwin M. Santo, MD Head, Invasive Endoscopy Unit Dep. of Gastroenterology.
Evaluation of Liver Histology in Clinical Trials for Chronic Viral Hepatitis Zachary Goodman, M.D., Ph.D. Chief, Hepatic Pathology Armed Forces Institute.
CHAPTER 23: Neurological Disorders in Women. Introduction Gender differences exist in the development and expression of several neurological disorders,
PATHOLOGY. -is a bridging discipline involving both basic science and clinical practice and is devoted to the study of the structural and functional changes.
Introduction: Medical Psychology and Border Areas
CLASSIFICATION OF CHRONIC PANCREATITIS EAGE, Podstgraduate Course, Prague, April Tomica Milosavljević Tomica Milosavljević School of Medicine, Clinical.
Patient Information - Viral Hepatitis B (HBV)
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Normal anatomy and histology. PANCREAS PANCREATITIS ACUTE (VERY SERIOUS) CHRONIC.
Cystic lesion of pancreas
Copyright © 2008 Delmar Learning. All rights reserved. Unit 6 Classification of Disease.
Introduction to Pathology Fall 2009 FINAL. Terms 1. _____________ is the study of disease. 2. _________ is any abnormal disturbance of function or structure.
KADA DA, A KADA NE ERCP Prof.dr.sc.Žarko Babić KB Dubrava, Zagreb Klinika za unutarnje bolesti Zavod za gastroenterologiju Odjel za gastroenterologiju.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
1 Differential Diagnosis of Neoplastic Pancreatic Cysts: The Role of EUS with Guided FNA E.M.Santo,Y.Ron,O.Barkay,Y.Kopelman,M.Leshno,S.Marmor Dep. of.
Hungarian Pancreatic Study Group – Magyar Hasnyálmirigy Munkacsoport Gábor Lakatos 09 november th Conference of the Hungarian & 2 nd Conference.
Pancreatic cancer.
New Strategies of the EPR-3. – Asthma is a chronic inflammatory disorder of the airways – The immunohistopathologic features of asthma include inflammatory.
Enrollment and Monitoring Procedures for NCI Supported Clinical Trials Barry Anderson, MD, PhD Cancer Therapy Evaluation Program National Cancer Institute.
Introduction to Pathology And its rule in the diagnostic process Dr: Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Dr. Jeyaparvathi Somasundaram
Cancers of the Digestive System November 19, 2007 NCDD Meeting Chair: John M. Carethers, MD Vice Chair: Robert Sandler, MD, MPH.
Diseases of the Oropharynx and Esophagus November 19, 2007 NCDD Meeting Chair: P. Jay Pasricha, MD Vice Chair: David A. Lieberman, MD.
Inflammatory Bowel Diseases November 19, 2007 NCDD Meeting Chair: Daniel K. Podolsky, MD Vice Chair: Eugene B. Chang, MD.
Pancreatic endoscopy : ROLE Of Endo TOF PET US Pr. René LAUGIER La Timone Hospital,Marseille MEDAMI Alghero, 4 th September 2014.
Integrated Pathology Practical Normal anatomy and histology.
Introduction to Pathology And its rule in the diagnostic process Dr. Atif Ali Bashir, MD Pathology Assistant Professor College of Medicine Majma’ah University.
Urothelial tumors Tumors in the collecting system above the bladder are relatively uncommon. These tumors are classified into : 1 benign papilloma. 2-papillary.
EBM Journal Club GS 謝閔傑. 題目 對於治療急性壞死性胰臟炎病患有需要使用抗生 素治療嗎?
R1. 이용석 / modulator pf. 동석호. Introduction Acute pancreatitis(AP) ▫most common disease that affects the pancreas ▫incidence of AP varies globally, affecting.
Characterstic of disease
Diseases of the Liver and Biliary System
General Pathology Introduction
Treatment of Pancreatitis MLTTP (case study)
RADICAL WHIPPLE`S PANCREATODUODENECTOMY FOR CHRONIC PANCREATITIS
Functional GI Disorders and Motility Disorders
Introduction to Pathology DR:Gehan mohamed
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and.
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
objectives Methods Results conclusion
Introduction to Pathology By Dr. Gehan Mohamed Dr. Abdelaty Shawky
Genetic Risk Factors for Pancreatic Disorders
Acute Pancreatitis (1) C.L.I.P.S.
Review of Anatomy and Physiology
Why study Brain tumour Biology???
Aaron Ritter MD Cleveland Clinic Lou Ruvo Center for Brain Health
ULTRASOUND NEWS
Presentation transcript:

Diseases of the Pancreas November 19, 2007 NCDD Meeting Chair: Jane Holt Vice Chair: P. Jay Pasricha, MD

Research Goal 1 Determine the biologic and genetic factors involved in the pathogenesis of acute pancreatitis with particular emphasis on mechanisms of tissue necrosis and systemic complications.

Research Goal 1 Objectives Understand how noxious insults such as ethanol or gallstones initiate pancreatic injury and inflammation. Understand the role of obesity, sphincter of Oddi dysfunction, and anatomic variations of the pancreas in the development of pancreatitis. Identify the biologic mechanisms leading to necrosis in acute pancreatitis.

Research Goal 1 Objectives (continued) Understand the biologic mechanisms responsible for post-ERCP pancreatitis. Understand the role of specific cytokines and other inflammatory factors including enteric bacteria and their products in the development of systemic complications and multi-organ failure.

Research Goal 2 Understand the transition from acute to chronic pancreatic injury, particularly with respect to the role of alcohol.

Research Goal 2 Objectives Understand how ethanol, smoking and other putative etiologic factors contribute to chronic injury. Determine the biology of pancreatic fibrosis and chronic injury including the role of stellate cells and other co-factors. Understand the nature and mechanism of endocrine cell loss in chronic pancreatitis.

Research Goal 2 Objectives (continued) Understand mechanisms of parenchymal and islet cell regeneration in response to chronic injury. Understand the biologic nature and importance of islet-parenchymal communication in the pancreas.

Research Goal 3 Understand genetic factors and how they interact with exogenous insults with respect to pathogenesis, complications, and natural history of pancreatitis and other pancreatic disorders.

Research Goal 3 Objectives Understand genetic factors that predispose to increased risk or severity of acute pancreatitis. Understand the role of genetic factors that predispose to chronic injury and/or impaired recovery from acute insults. Understand gene-environmental interactions in the development of benign and cystic neoplasms as well as pancreatic cancer arising in the context of chronic pancreatitis.

Research Goal 3 Objectives (continued) Understand the genetic factors that predispose to sensitization and pain in the setting of pancreatic injury. Develop novel models of pancreatic disease derived from targeting of specific genes.

Develop and validate therapeutic interventions for treatment and/or progression of pancreatitis and its complications. Research Goal 4

Research Goal 4 Objectives Study the effects of specific pharmacologic therapies, including anti-cytokine agents for the treatment of acute pancreatitis, prevention, and treatment of necrosis and multi-organ failure. Study novel and more effective pharmacologic and/or endoscopic approaches to prevent ERCP-induced pancreatitis.

Research Goal 4 Objectives (continued) Study the effect of endoscopic approaches (e.g. stents, stone removal and stricture formation), surgery, and radiologic interventions for the treatment of organized necrosis, pseudocysts, pain and other complications of acute and pancreatitis. Study novel pharmacologic approaches for the reversal of fibrosis and prevention of islet and parenchymal cell loss including islet cell and stem cell transplant strategies.

Research Goal 4 Objectives (continued) Study the role of immunosuppressive therapy for the treatment of autoimmune pancreatitis.

Understand the neurobiology of the pancreas with respect to mechanisms of pain and neurogenic inflammation. Research Goal 5

Research Goal 5 Objectives Study the biologic basis and mechanisms responsible for peripheral sensitization in chronic pancreatitis. Study changes in central sensitization and the underlying mechanisms in patients with painful chronic pancreatitis.

Research Goal 5 Objectives (continued) Understand the biologic basis of narcotic dependence and resistance in patients with chronic pancreatitis. Identify novel therapeutic targets for more effective analgesic therapy.

Research Goal 5 Objectives (continued) Understand the mechanisms by which autonomic, spinal, and neurohormonal factors influence the course of acute and chronic pancreatitis and their complications.

Define the epidemiology and clinical course of acute and chronic pancreatitis, including alcoholic pancreatitis, autoimmune pancreatitis, and cystic fibrosis through population-based studies in adults and children. Research Goal 6

Research Goal 6 Objectives Identify reliable prognostic factors of severity of acute pancreatitis at admission that can be utilized to stratify patients that can be enrolled in studies that evaluate new therapies. Understand the co-factors necessary for development of fibrosis in patients with recurrent pancreatitis and rate of disease progression in chronic pancreatitis.

Research Goal 6 Objectives (continued) Understand the natural history of disease in patients with chronic pancreatitis due to various etiologies including autoimmune pancreatitis. Understand demographic, ethnic, genetic and environmental factors enhancing risk of disease development and rate of disease progression.

Research Goal 6 Objectives (continued) Develop and validate reliable measures of pain and quality of life in patients with chronic pancreatitis.

Research Goal 7 Develop more accurate and useful approaches to the diagnosis of chronic pancreatitis by functional, radiologic, endoscopic, or pathologic/cytologic means.

Research Goal 7 Objectives Develop and validate unequivocal criteria for diagnosis of chronic pancreatitis (histologic and non-histologic) and distinguish etiopathologic subsets, such as autoimmune or genetic pancreatitis. Study novels methods including minimally invasive biopsy methods to help identify patients with early chronic pancreatitis and distinguish etiopathologic subsets.

Research Goal 7 Objectives (continued) Develop and validate novel and less invasive methods to recognize and monitor fibrosis. Develop and validate more accurate and convenient tests to assess and monitor pancreatic function.

Research Goal 7 Objectives (continued) Develop and validate reliable non-invasive methods for the diagnosis and monitoring of autoimmune pancreatitis.

Research Goal 8 Define the role of pathologic lesions, such as pancreatic intraepithelial neoplasms (PanINs) and other factors that may correlate with the risk of malignant transformation in chronic pancreatitis and cystic neoplasms and map their morphologic and molecular progression.

Research Goal 8 Objectives Study the epidemiology and natural history of cystic disorders of the pancreas and correlation with results of imaging and fluid analysis. Identify biomarkers in cystic fluid and tissue aspirates for providing unequivocal diagnoses and pathologic distinction.

Research Goal 8 Objectives (continued) Study the role of invasive and non-invasive methods for surveillance of patients at risk for malignancy. Study of clinico-pathologic correlations involving PanINs, small cystic lesions, and IPMN.

Research Goal 8 Objectives (continued) Studies on the genetic and morphologic progression between precursor lesions and pancreatic cancer particularly in the context of chronic pancreatitis.

Major Challenges/Steps To Achieve Goals Standards for diagnosis National resources for pancreas research Animal models Alignment of research and clinical forces

Major Challenges/Steps To Achieve Goals Standards for Diagnosis Consensus guidelines for diagnosis of chronic pancreatitis and (including histologic and clinical criteria) Reliable tools to measure of pain and quality of life in patients with chronic pancreatitis National Resources for Pancreas Research National database of acute pancreatitis to define mortality and morbidity and to develop reliable prognostic factors of severity at admission Patient registry and a repository of biologic samples Multicenter consortia for the study of chronic pancreatitis in adults and children

Major Challenges/Steps To Achieve Goals Animal Models Animal models of both acute and chronic pancreatitis (alcoholic and non- alcoholic) and its complications Alignment of Research and Clinical Forces Rapid development of endoscopic and other relatively non-invasive approaches to the pancreas has resulted in some divergence between the biologic and clinical approaches to understanding diseases of the pancreas. A concerted effort to re-align these forces is important.